Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biol Trace Elem Res ; 167(1): 84-90, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-25749926

RESUMO

Various fluoride compounds are widely used in industry. The present risk assessment study was conducted using a series of inorganic binary fluorides of the type XFn, where X(n) = Na(+), K(+), Li(+), Mg(2+), Ca(2+), Sr(2+), Ba(2+), Al(3+), Nd(3+), La(3+), Ce(3+), Sm(3+), Gd(3+), Y(3+), Yb(2+), and Zn(2+). The aqueous solutions of these salts were orally administrated to 16 experimental groups (one for each of the salts tested). The levels of fluoride, N-acetyl-ß-D-glucosaminidase in cumulative 24-h urine samples and creatinine clearance were measured to assess possible acute renal damages. The levels of fluoride, alanine aminotransferase, and aspartate aminotransferase were also determined in serum samples to assess possible acute hepatic damages. The results reveal that sodium fluoride (NaF), potassium fluoride (KF), and zinc fluoride tetrahydrate (ZnF2 (.)4H2O) can carry the fluoride ion into the bloodstream and that it is excreted via urine more readily than the other compounds tested. These fluorides were assigned the highest risk impact factor. Most of the rare earth fluorides are insoluble in water while those groups 2 and 13 of the periodic table are slightly soluble, so that they do not have a significant negative risk. These findings suggest that the biological impact of fluoride depends on the accompanying counter ion and its solubility. The risk map obtained in the present study shows that the graphical visualization map technique employed is a valuable new tool to assess the toxicological risk of chemical compounds.


Assuntos
Fluoretos/sangue , Fluoretos/urina , Medição de Risco/métodos , Medição de Risco/estatística & dados numéricos , Acetilglucosaminidase/urina , Injúria Renal Aguda/sangue , Injúria Renal Aguda/diagnóstico , Injúria Renal Aguda/urina , Administração Oral , Alanina Transaminase/sangue , Animais , Aspartato Aminotransferases/sangue , Doença Hepática Induzida por Substâncias e Drogas/sangue , Doença Hepática Induzida por Substâncias e Drogas/diagnóstico , Doença Hepática Induzida por Substâncias e Drogas/urina , Fluoretos/administração & dosagem , Masculino , Compostos de Potássio/administração & dosagem , Compostos de Potássio/sangue , Compostos de Potássio/urina , Ratos Wistar , Fatores de Risco , Fluoreto de Sódio/administração & dosagem , Fluoreto de Sódio/sangue , Fluoreto de Sódio/urina , Compostos de Zinco/administração & dosagem , Compostos de Zinco/sangue , Compostos de Zinco/urina
2.
Med Tr Prom Ekol ; (6): 35-9, 2014.
Artigo em Russo | MEDLINE | ID: mdl-25282813

RESUMO

Repeated intraperitoneal injections of nickel and chromium (VI) into rats appeared to demonstrate that the combined subchronic toxicity can be additive or vary (mostly to subadditivity) in accordance with effect on which they are evaluated. With moderate general toxic effects, the studied combination has marked genotoxicity with additive effect. The studies demonstrated reciprocal influence of nickel and chromium on accumulation of the second metal in some organs (especially, in spleen), but not on its renal excretion.


Assuntos
Cromatos/farmacocinética , Cromatos/toxicidade , Níquel/farmacocinética , Níquel/toxicidade , Compostos de Potássio/farmacocinética , Compostos de Potássio/toxicidade , Animais , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Encéfalo/patologia , Cromatos/sangue , Cromatos/urina , Fragmentação do DNA/efeitos dos fármacos , Sinergismo Farmacológico , Rim/efeitos dos fármacos , Rim/metabolismo , Rim/patologia , Fígado/efeitos dos fármacos , Fígado/metabolismo , Fígado/patologia , Níquel/sangue , Níquel/urina , Especificidade de Órgãos , Compostos de Potássio/sangue , Compostos de Potássio/urina , Ratos , Baço/efeitos dos fármacos , Baço/metabolismo , Baço/patologia , Testes de Toxicidade Subcrônica
3.
J Nutr Sci Vitaminol (Tokyo) ; 59(3): 187-97, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23883689

RESUMO

We studied the effects of dietary mineral source and oil intake on kidney calcification in 4-wk-old female Fischer rats after consuming the AIN-76 purified diet (AIN-76). A modified AIN-76 mineral mixture was used, although the original calcium (Ca)/phosphorus (P) molar ratio remained unchanged. Rats were fed the modified diets for a period of 40 d before their kidneys were removed on the last day. Ca balance tests were performed on days 31 to 36 and biochemical analysis of urine was also studied. Kidney Ca, P, and magnesium (Mg) in the standard diet group (20% protein and 5% oil) were not affected by the mineral source. Kidney Ca, P, and Mg in the low-protein (10% protein) diet group, were found to be influenced by the dietary oil content and mineral source. In particular, the different mineral sources differentially increased kidney mineral accumulation. Pathological examination of the kidney showed that the degree of kidney calcification was proportional to the dietary oil content in the 10% dietary protein group, reflecting the calcium content of the kidney. The information gathered on mineral sources in this study will help future researchers studying the influence of dietary Ca/P molar ratios, and histological changes in the kidney.


Assuntos
Calcinose/induzido quimicamente , Cálcio da Dieta/administração & dosagem , Dieta , Rim/efeitos dos fármacos , Minerais , Fósforo na Dieta/administração & dosagem , Óleo de Soja/administração & dosagem , Animais , Calcinose/metabolismo , Calcinose/patologia , Calcinose/urina , Citrato de Cálcio/metabolismo , Citrato de Cálcio/farmacologia , Citrato de Cálcio/urina , Fosfatos de Cálcio/metabolismo , Fosfatos de Cálcio/farmacologia , Fosfatos de Cálcio/urina , Cálcio da Dieta/metabolismo , Cálcio da Dieta/farmacologia , Cálcio da Dieta/urina , Proteínas Alimentares/administração & dosagem , Feminino , Rim/metabolismo , Rim/patologia , Magnésio/metabolismo , Magnésio/urina , Minerais/administração & dosagem , Minerais/metabolismo , Minerais/urina , Fosfatos/administração & dosagem , Fosfatos/metabolismo , Fosfatos/farmacologia , Fosfatos/urina , Fósforo na Dieta/metabolismo , Fósforo na Dieta/farmacologia , Fósforo na Dieta/urina , Compostos de Potássio/metabolismo , Compostos de Potássio/farmacologia , Compostos de Potássio/urina , Ratos , Ratos Endogâmicos F344 , Óleo de Soja/farmacologia
4.
Br J Nutr ; 94(2): 192-7, 2005 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16115352

RESUMO

Low-grade metabolic acidosis, consecutive to excessive catabolism of sulfur amino acids and a high dietary Na:K ratio, is a common feature of Western food habits. This metabolic alteration may exert various adverse physiological effects, especially on bone, muscle and kidneys. To assess the actual effects of various K salts, a model of the Westernised diet has been developed in rats: slight protein excess (20 % casein); cations provided as non-alkalinising salts; high Na:K ratio. This diet resulted in acidic urine (pH 5.5) together with a high rate of divalent cation excretion in urine, especially Mg. Compared with controls, K supplementation as KCl accentuated Ca excretion, whereas potassium bicarbonate or malate reduced Mg and Ca excretion and alkalinised urine pH (up to 8). In parallel, citraturia was strongly increased, together with 2-ketoglutarate excretion, by potassium bicarbonate or malate in the diet. Basal sulfate excretion, in the range of 1 mmol/d, was slightly enhanced in rats fed the potassium malate diet. The present model of low-grade metabolic acidosis indicates that potassium malate may be as effective as KHCO3 to counteract urine acidification, to limit divalent cation excretion and to ensure high citrate concentration in urine.


Assuntos
Aminoácidos Sulfúricos/administração & dosagem , Dieta/efeitos adversos , Suplementos Nutricionais/efeitos adversos , Potássio/farmacologia , Acidose/metabolismo , Aminoácidos Sulfúricos/metabolismo , Amônia/urina , Animais , Bicarbonatos/administração & dosagem , Bicarbonatos/urina , Cálcio/sangue , Cálcio/urina , Dieta/métodos , Ingestão de Alimentos/fisiologia , Magnésio/sangue , Magnésio/urina , Malatos/metabolismo , Masculino , Potássio/administração & dosagem , Potássio/urina , Cloreto de Potássio/administração & dosagem , Cloreto de Potássio/urina , Compostos de Potássio/administração & dosagem , Compostos de Potássio/urina , Ratos , Ratos Wistar , Sódio/sangue , Sódio/urina , Sulfatos/urina , Micção/fisiologia , Aumento de Peso/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...